Literature DB >> 17503668

Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy.

Dorothea M Wunder1, Nick A Bersinger, Christoph A Fux, Nicolas J Mueller, Bernard Hirschel, Matthias Cavassini, Luigia Elzi, Patrick Schmid, Enos Bernasconi, Bruno Mueller, Hansjakob Furrer.   

Abstract

OBJECTIVES: To assess the prevalence of abnormal testosterone and gonadotropin values in HIV-infected men before and after 2 years of combination antiretroviral therapy (cART).
DESIGN: Multicentre cohort of HIV-infected adults.
METHODS: We identified 139 Caucasian antiretroviral-naive male patients who started zidovudine/ lamivudine-based cART that was virologically successful over a 2 year period. Ninety-seven were randomly chosen and plasma hormone determinations of free testosterone (fT) and luteinizing hormone (LH) at baseline and after 2 years of cART were evaluated.
RESULTS: At baseline 68 patients (70%) had subnormal fT levels. In these, LH levels were low in 44%, normal in 47% and high in 9%. There was a trend for an association between lower CD4+ T-cell counts and hypogonadism. Most participants had normal FSH levels. No significant changes of fT, LH and FSH levels were observed after 2 years of cART.
CONCLUSIONS: Low fT levels, mainly with normal or low LH levels and thus indicating secondary hypogonadism, are found in the majority of HIV-infected men and do not resolve during 2 years of successful cART.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503668

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  28 in total

Review 1.  Management of the metabolic effects of HIV and HIV drugs.

Authors:  Todd T Brown; Marshall J Glesby
Journal:  Nat Rev Endocrinol       Date:  2011-09-20       Impact factor: 43.330

2.  Bone alterations associated with HIV.

Authors:  Amy H Warriner; Michael Mugavero; E Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2014-09       Impact factor: 5.071

3.  Testosterone and Abnormal Glucose Metabolism in an Inner-City Cohort.

Authors:  Anne K Monroe; Adrian S Dobs; Joseph Cofrancesco; Todd T Brown
Journal:  J Mens Health       Date:  2012-09       Impact factor: 0.537

Review 4.  Management of fat accumulation in patients with HIV infection.

Authors:  Julian Falutz
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

5.  Fasting Triglyceride Concentrations are Associated with Early Mortality Following Antiretroviral Therapy in Zambia.

Authors:  Julius N Ngu; Douglas C Heimburger; Donna K Arnett; Christopher K Nyirenda; Dara Potter; Isaac Zulu; Claire N Bosire; Shashwatee Bagchi; Jiatao Ye; Benjamin H Chi; Edmond K Kabagambe
Journal:  N Am J Med Sci (Boston)       Date:  2010

6.  Sex hormones, insulin resistance, and diabetes mellitus among men with or at risk for HIV infection.

Authors:  Anne K Monroe; Adrian S Dobs; Xiaoqiang Xu; Frank J Palella; Lawrence A Kingsley; Mallory D Witt; Todd T Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

Review 7.  Management of prostate cancer in HIV-positive patients.

Authors:  Matthew S Wosnitzer; Franklin C Lowe
Journal:  Nat Rev Urol       Date:  2010-04-27       Impact factor: 14.432

8.  Risk of Breast, Prostate, and Colorectal Cancer Diagnoses Among HIV-Infected Individuals in the United States.

Authors:  Anna E Coghill; Eric A Engels; Maria J Schymura; Parag Mahale; Meredith S Shiels
Journal:  J Natl Cancer Inst       Date:  2018-09-01       Impact factor: 13.506

9.  The Study of Gonadal Hormonal Abnormalities and Sexual Dysfunction in HIV Positive Females: An Exploratory Study.

Authors:  Bhanukumar Muthiah; Abithraj Kallikadavil; Rajendraprasad Shivaswamy; Vineetha Bharathan Menon
Journal:  J Clin Diagn Res       Date:  2016-04-01

Review 10.  Hypogonadism in human immunodeficiency virus-positive men.

Authors:  Jane Ashby; David Goldmeier; Hossein Sadeghi-Nejad
Journal:  Korean J Urol       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.